04:09 PM EST, 02/21/2025 (MT Newswires) -- Peter Salzmann, Director, Chief Executive Officer, on February 19, 2025, sold 15,439 shares in Immunovant ( IMVT ) for $322,058. Following the Form 4 filing with the SEC, Salzmann has control over a total of 948,786 common shares of the company, with 948,786 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1764013/000176401325000030/xslF345X05/wk-form4_1740171852.xml